KING OF PRUSSIA, Pa., March 1, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference in New York, New York on Thursday, March 2, 2023 at 3:30pm (EST).
A live audio webcast of the presentation will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, a replay of the presentation will be available on the Company's website for 90 days following the conference.
Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.
| Last Trade: | US$174.80 |
| Daily Change: | 1.14 0.66 |
| Daily Volume: | 537,445 |
| Market Cap: | US$10.260B |
March 11, 2025 February 26, 2025 October 29, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
